EssilorLuxottica Acquires Optegra, Expanding its Med-Tech Strategy
Deal News | May 30, 2025 | Finance Community IT - 1 Corporate M&A
EssilorLuxottica, a prominent player in the global eyewear industry, has announced the acquisition of Optegra, a rapidly growing ophthalmic platform operating in key European markets including the UK, Czech Republic, Poland, Slovakia, and the Netherlands. The acquisition, assisted by financial advisor Rothschild & Co, marks a pivotal step in EssilorLuxottica's med-tech strategy, aimed at expanding their offerings to include cutting-edge AI technologies, wearables, medical equipment, and innovative sight care solutions. Optegra, which operates a vast network of over 70 eye hospitals and diagnostic centers, offers essential and elective eye treatments that are highly supported by AI in both pre- and post-operative phases. This strategic acquisition aligns with EssilorLuxottica’s goal to provide a comprehensive integrated platform for vision care, enhancing diagnostics and treatment solutions while integrating advanced technologies. The transaction, expected to finalize by 2025, is contingent upon regulatory approvals. MidEuropa, the selling private equity firm, has significantly contributed to Optegra's growth and digital transformation, expressing confidence in EssilorLuxottica as the ideal partner to lead Optegra into its next growth phase.
Sectors
- Healthcare & Medical Devices
- Private Equity & Venture Capital
- Artificial Intelligence & Technology
Geography
- United Kingdom – Optegra operates within the UK, which is one of the key markets for the acquisition.
- Czech Republic – The Czech Republic is one of the strategic markets where Optegra operates.
- Poland – Poland is included among Optegra's strategic markets in Europe.
- Slovakia – Slovakia represents a strategic market for Optegra's operations.
- Netherlands – The Netherlands is another key market for Optegra, emphasized in the article's context.
Industry
- Healthcare & Medical Devices – The article discusses the acquisition of Optegra, an ophthalmic platform, which is directly related to the healthcare and medical devices industry.
- Private Equity & Venture Capital – The involvement of MidEuropa, a private equity firm, indicates the relevance of this industry, as it plays a critical role in the acquisition process.
- Artificial Intelligence & Technology – EssilorLuxottica aims to integrate advanced AI technologies in their offerings, highlighting the role of the technology sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EssilorLuxottica | Acquirer | Company | A leading global eyewear company, expanding its med-tech capabilities through strategic acquisitions. |
| Optegra | Target Company | Company | An ophthalmic platform operating in key European markets, offering advanced eye care solutions. |
| MidEuropa | Vendor | PE Firm | A private equity firm that is selling Optegra to EssilorLuxottica. |
| Rothschild & Co | Financial Advisor | Company | Advising EssilorLuxottica on the acquisition with a specialized team. |